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Abstract
Background:  The toxic effects of many simple organic compounds stem from their
biotransformation to chemically reactive metabolites which bind covalently to cellular proteins. To
understand the mechanisms of cytotoxic responses it may be important to know which proteins
become adducted and whether some may be common targets of multiple toxins. The literature of
this field is widely scattered but expanding rapidly, suggesting the need for a comprehensive,
searchable database of reactive metabolite target proteins.
Description: The Reactive Metabolite Target Protein Database (TPDB) is a comprehensive,
curated, searchable, documented compilation of publicly available information on the protein
targets of reactive metabolites of 18 well-studied chemicals and drugs of known toxicity. TPDB
software enables i) string searches for author names and proteins names/synonyms, ii) more
complex searches by selecting chemical compound, animal species, target tissue and protein names/
synonyms from pull-down menus, and iii) commonality searches over multiple chemicals. Tabulated
search results provide information, references and links to other databases.
Conclusion:  The TPDB is a unique on-line compilation of information on the covalent
modification of cellular proteins by reactive metabolites of chemicals and drugs. Its
comprehensiveness and searchability should facilitate the elucidation of mechanisms of reactive
metabolite toxicity. The database is freely available at http://tpdb.medchem.ku.edu/tpdb.html
Background
The toxic effects of many simple organic chemicals, pol-
lutants and even drugs are associated with their biotrans-
formation to chemically reactive intermediates [1,2]. The
latter in turn react covalently with cellular macromole-
cules, thus modifying their structure and potentially their
function. Whereas modification of DNA can cause muta-
tions or even cancer, protein modification is often associ-
ated with direct, acute cytotoxic effects. Protein covalent
binding is usually detected by administering radioactive
precursors to animals (or cell-based systems in vitro) and
measuring the amount of radioactivity that becomes cov-
alently attached to the macromolecules (i.e., not remova-
ble by dialysis, extraction or chromatography) [3].
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The extent, time course and anatomical distribution of
protein covalent binding generally correlate very well with
similar measures of target organ toxicity in whole animals
or cellular systems. However, a few prominent exceptions
to this pattern are also known. For example, whereas bro-
mobenzene and p-acetamidophenol (acetaminophen)
are "textbook" pro-toxins, p-bromophenol [4] and m-
acetamidophenol [5,6] are essentially nontoxic despite
the fact that they undergo metabolic activation and cova-
lent binding much like their toxic congeners. These and
other examples indicate that while covalent binding is
apparently necessary for toxicity, not all covalent binding
is  sufficient  to cause toxicity. Since most biological
responses to chemicals are highly structurally specific, to
understand the mechanisms of cytotoxic responses it is
imperative to understand the structural chemistry of pro-
tein covalent binding.
The enzymes of xenobiotic metabolism generally have a
rather broad substrate specificity that appears to be gov-
erned primarily by the functional group chemistry of
potential substrates [7]. Since the early 1970s, considera-
ble progress has been made in identifying the reactive
metabolites formed from a large number of chemical
functional groupings [8]. In the vast majority of cases they
are electrophilic in nature. For example, epoxides, qui-
nones and Michael acceptors generally react with cysteine
sulfhydryl groups but also react with lysine, histidine and,
to a lesser extent, methionine or even carboxylic acid side
chains in proteins [9-11]. On the other hand metabolites
such as acyl- and thioacyl halides and iminosulfinic acids
show a strong tendency to acylate the epsilon-amino
group of lysine side chains (Figure 1) [12-14].
In contrast to the wealth of structural information about
cytotoxic metabolites, knowledge of their protein targets
has been much slower to accumulate. The earliest identi-
fications of reactive metabolite target proteins were based
on classical isolation and N-terminal sequencing of radio-
active proteins from animals treated with radiolabeled
pro-toxins [15,16]. Subsequent reports have appeared
sporadically and thus are scattered throughout the litera-
ture, making global comparisons or analyses difficult.
Since the advent of modern mass spectrometry-based
methods, longer lists of target proteins have been identi-
fied [17-20] but the literature still remains fragmented.
Our laboratory has been interested in exploring the possi-
bility that different pro-toxins target a common subset of
proteins whose covalent modification might be mecha-
nistically significant to cytotoxicity [17,21,22]. To test this
hypothesis required that we collect, organize and analyze
essentially all of the publicly available information about
well-identified target proteins that become adducted by
reactive metabolites of organic chemical pro-toxins. The
Reactive Metabolite Target Protein Database (TPDB) and
the associated analysis software described herein were cre-
ated to facilitate this task.
Construction and content
The Reactive Metabolite Target Protein Database (TPDB)
was implemented as an Oracle 9i relational database. An
interactive web interface was created using Java Server
Pages (JSP) and the Java Database Connectivity (JDBC)
API was used to interface with the Oracle database. Cur-
rently our server runs on the LINUX operating system
(RedHat AS3). The database is freely accessible on the web
and the schema of the database design is available on the
website.
Populating the database
Computerized literature searches for "protein adducts"
and similar terms yield more than 1500 references. How-
ever, the vast majority of these simply report occurrences
of protein covalent binding detected in model systems, in
occupational health screenings based on hemoglobin
adducts ("molecular dosimetry"), or during in vitro
screening tests associated with drug development pipe-
lines. These reports generally fail to provide information
about target protein identity or the relevance of the bind-
ing events to cytotoxicity and/or target organ toxicity.
Thus, despite their value for kinetic and/or structural stud-
ies, reports of in vitro adduct formation in "model" sys-
tems using microsomes, purified enzymes, synthesized
metabolites, or prepurified target proteins are not
included in the TPDB at this time. Instead, we used infor-
mation collected from original literature reports of spe-
cific identifications of target proteins for reactive
metabolites derived from drugs and chemicals that have
been well studied in the context of toxicology. Only
results from studies conducted in vivo or in living cells/tis-
sues are included, but subject to this restriction the collec-
tion is believed to be essentially complete. Most of the
data came from experiments done in mice or rats,
although a few human observations are included. Infor-
mation about oxidative damage to proteins caused by
reactive oxygen or -nitrogen species (ROS, RNS), or mod-
ifications by endogenous products of lipid peroxidation
have not been included, although these areas are obvious
opportunities for future expansion of the TPDB.
A simple but efficient data entry routine was implemented
to facilitate populating the database. At each entry cycle
the name of the small molecule (i.e., chemical or drug),
the species and tissue involved, the name of the target pro-
tein identified, notes about the separation and identifica-
tion methods employed, and the original literature
reference were entered. In addition a flag (public/private)
is set to allow us to enter, check and/or analyze "in house"
and other data prior to incorporating it into the publicBMC Bioinformatics 2007, 8:95 http://www.biomedcentral.com/1471-2105/8/95
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database. For each entry a unique protein ID number was
generated for internal use by the database software. When
highly similar target proteins (e.g. isoforms from the same
species or orthologous proteins from different species) were
specifically and uniquely identified and reported as target
proteins they were numbered and listed as distinct pro-
teins in the database. However, for purposes of assessing
commonality of targeting (see below), highly similar iso-
forms and orthologs are regarded as being the same pro-
tein according to a look-up table created for this purpose.
A comments (text) field was also established for each pro-
tein entry. After the initial entry phase was complete, sup-
plementary information was added for each protein as
indicated in Table 1. Each entry was double-checked
against the original literature prior to setting its flag to
public access. Thus, we believe that the data contained in
the TPDB are highly reliable.
Searching the database
The web-accessible search page is organized into three sec-
tions plus a link to a Help Page that gives explanations
and examples. The first section reports the results of four
automatic searches to determine the number of small
molecule pro-toxins and literature references in the data-
base (currently 18 and 52, respectively). The software also
reports the total number of protein hits (a hit is defined as
one adduct on one protein reported in one reference) and
the number of non-redundant protein entries in the data-
base. Currently the TPDB contains 152 hits comprising
121 non-redundant proteins having 458 synonyms in the
literature. This section also allows string searches for
author surnames and protein names. For example, search-
ing the string < dehyd > finds one "dehydratase" and 12
"dehydrogenase" proteins in the database. Clicking on
any of the protein ID numbers generates an output table
as described below.
The second section of the search page enables custom
searches  via four pull-down menus: Chemical, Target
Species, Target Tissue and Protein Name. The default entry
in each menu is "any (all);" thus the default search returns
a table of all entries in the database (see Output section
below). Custom searching is highly intuitive. For exam-
ple, selecting just a chemical name (i.e. searching for <
chemical, any, any, any >) will return all proteins in the
database that are adducted by that chemical. This search
can be refined by also selecting a target tissue. For exam-
ple, searching < halothane, any, liver, any > will find all
hepatic proteins known to be adducted by halothane
metabolites. Numerous search combinations of < chemi-
cal, species, tissue, protein > are possible (although not all
will produce results if there are no reported examples).
Formation of chemically reactive metabolites from stable pro-toxins Figure 1
Formation of chemically reactive metabolites from stable pro-toxins.BMC Bioinformatics 2007, 8:95 http://www.biomedcentral.com/1471-2105/8/95
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Structure of information output
In general, search outputs are in the form of viewable,
printable tables containing specific information and
hyperlinks (Figure 2). For example, searching for target
proteins of a small molecule (pro-toxin) produces a table
containing the following information for each target pro-
tein of that small molecule: 1) the common name of the
protein; 2) the small molecule name; 3) a summary of the
target species and tissue, the type of evidence on which the
identification was based, and the separation method(s)
used; 4) the TPDB database protein ID# as a hyperlink to
a secondary table that lists the ID#, names/synonyms,
species of origin, molecular weight, isoelectric point, com-
ments (if any were added when the protein was entered),
Swiss-Prot and NCBI accession numbers (as active hyper-
links), and the PDB entry code (as a hyperlink, if availa-
ble); and 5) a reference in the form of a hyperlink to the
full citation information including the PubMed ID
number (as an active hyperlink).
Utility and discussion
In addition to the searches for specific items of informa-
tion mentioned above, the TPDB also offers two types of
global searches. The "Commonality Matrix" function
produces a N × N matrix, where N is the number of small
molecules in the database. Each diagonal element gives
the number of proteins known to be adducted by the par-
ticular chemical whose row and column intersect on the
diagonal. This allows a quick visual assessment of the
extent to which various pro-toxins have been studied (and
where additional studies might be needed). The off-diag-
onal elements give the number of proteins targeted by
both of the chemicals whose row and column intersect at
that off-diagonal element. Each element in the common-
ality matrix is also a hyperlink that leads to a table provid-
ing information about all the relevant proteins in the
format described above.
Deeper insight into the common targeting of certain pro-
teins by multiple pro-toxins is provided by a second global
search function that provides a ranking of all proteins by
the number of different chemicals which "hit" them. In
this list, each protein ID number is a hyperlink that pro-
vides detailed information about that protein as described
above. Using this function one finds that among the 121
non-redundant protein entries, only one protein (protein
disulfide isomerase A1) is targeted by reactive metabolites
of four different chemicals (acetaminophen, m-acetami-
dophenol, benzene and naphthalene). Only two proteins
(selenium binding proteins 1 and 2) are targeted by reac-
tive metabolites of three different pro-toxins, while 20
proteins are common to at least two of the 18 pro-toxins
covered. The remaining 98 proteins in the database are all
singletons as far as is known at present.
Thus, based on information collected from the open liter-
ature, commonality of protein targeting seems to be a pat-
tern that is emerging slowly if at all. On the other hand,
unpublished data from our laboratory reveals that bro-
mobenzene (45 known target proteins in rat liver)
[17,21,23] and thiobenzamide (71 known target proteins
in rat liver; Koen et al., manuscript in preparation) share
28 protein targets in common. We expect that as target
lists for individual compounds grow larger, commonality
of targeting will start to become much more apparent. It is
important to note, however, that covalent binding is a
selective process and not a random process that is simply
proportional to protein abundance, as discussed in ref.
[24]. At present, the mechanistic significance of this com-
monality remains an open question, and a worthwhile
direction for future research.
Conclusion
The TPDB is a unique, web-accessible, searchable compi-
lation of published data concerning the identification of
cellular proteins targeted by electrophilic, chemically reac-
tive metabolites of chemicals and drugs under in vivo or
in-cell conditions. It is thought to be comprehensive or
very nearly so in its listing of target proteins, and it is
updated as new information emerges. Its data can be
accessed and analyzed using a number of built-in search
routines, and the results can be sorted and printed. The
current content of 152 hits (121 non-redundant proteins)
from studies with the 18 small molecule pro-toxins for
which any protein target has been identified, is expected
to rise significantly as recent advances in techniques for
Table 1: Information contained in the database for each protein entry
Protein name (and synonyms) found in the literature or other databases
Adduct-forming pro-toxin (small molecule)
Animal species and target tissue
Type of evidence on which protein identification was based
Separation method(s) used
Protein molecular weight and isoelectric point (MW and pI)
Swiss-Prot accession number (as a hyperlink)
NCBI accession number (as a hyperlink)
PDB entry (as a hyperlink, if available)
Full citation to original literature (with PMID number as a hyperlink)BMC Bioinformatics 2007, 8:95 http://www.biomedcentral.com/1471-2105/8/95
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identifying proteins by mass spectrometry are more
widely applied. It is hoped that diverse researchers and
bio-informaticians, particularly those in industry [25],
will both contribute to and analyze the content of the
TPDB, and that as it grows it will prove useful for elucidat-
ing mechanisms of chemical toxicity.
Availability and requirements
The database is freely accessible at http://tpdb.med
chem.ku.edu/tpdb.html It has been tested to work with
Mozilla Firefox 2.0 and Internet Explorer 6.0. Some fea-
tures may not work with other browsers (e.g. Mac Safari
2.0).
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